Craig-Hallum Reiterates Buy on CareDx, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Connor Chamberlain has reiterated a Buy rating on CareDx (NASDAQ:CDNA) and maintained a $15 price target on the stock.
May 09, 2024 | 4:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CareDx receives a reiterated Buy rating and a maintained $15 price target from Craig-Hallum analyst Connor Chamberlain.
The reiteration of a Buy rating and maintenance of a $15 price target by a reputable analyst like Connor Chamberlain could instill confidence in investors and potentially lead to a positive short-term impact on CareDx's stock price. Analyst ratings often influence investor perception and can lead to price movements.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100